Written Question·Department of Health and Social Care·UIN 109998

Cystic Fibrosis: Drugs

Tabled: 2 February 2026
Answered: 9 February 2026

Question

Jim Shannon

Democratic Unionist PartyStrangford

To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that people with cystic fibrosis have access to Orkambi, Symkevi and Kaftrio on the NHS.

Answer

Dr Zubir Ahmed
In July 2024, National Institute for Health and Care Excellence (NICE) approved three disease modifying treatments, Orkambi, Symkevi, and Kaftrio, as treatment options for eligible National Health Service patients with cystic fibrosis, under the terms of ...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 109998) →